Cargando…

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

INTRODUCTION: Young African women bear a disproportionately high risk for HIV acquisition. HIV technologies that empower women to protect themselves are needed. Safe, potent antiretroviral agents such as tenofovir alafenamide (TAF), formulated as long-acting subdermal implants, offer an innovative s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gengiah, Tanuja Narayansamy, Abdool Karim, Quarraisha, Harkoo, Ishana, Mansoor, Leila, Zuma, Nonhlanhla Yende, Radebe, Precious, Samsunder, Natasha, Baxter, Cheryl, Maharaj, B, Baum, Marc M, Moss, John A, Pozzetto, Bruno, Hankins, Catherine, Abdool Karim, Salim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	HIV/AIDS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739430/ https://www.ncbi.nlm.nih.gov/pubmed/34992111 http://dx.doi.org/10.1136/bmjopen-2021-052880

Ejemplares similares

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
por: Mahomed, Sharana, et al.
Publicado: (2023)

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004
por: Castor, Delivette, et al.
Publicado: (2022)

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial
por: Karim, Quarraisha Abdool, et al.
Publicado: (2011)

Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
por: Matthews, Lynn T., et al.
Publicado: (2013)

Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
por: Mansoor, Leila E., et al.
Publicado: (2022)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
por: Kharsany, Ayesha BM, et al.
Publicado: (2012)

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
por: Mahomed, Sharana, et al.
Publicado: (2020)

Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2019)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
por: Mahomed, Sharana, et al.
Publicado: (2022)

Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study
por: MacQueen, Kathleen M., et al.
Publicado: (2014)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study
por: van Loggerenberg, Francois, et al.
Publicado: (2008)

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
por: Burgers, WA, et al.
Publicado: (2012)

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision
por: Humphries, Hilton, et al.
Publicado: (2022)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
por: Chopera, Denis R., et al.
Publicado: (2013)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2014)

Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa
por: Montague, Carl, et al.
Publicado: (2014)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Current status of the HIV epidemic & challenges in prevention
por: Karim, Quarraisha Abdool
Publicado: (2017)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa
por: Kharsany, Ayesha B. M., et al.
Publicado: (2019)

A cluster‐randomized controlled trial to improve the quality of integrated HIV‐tuberculosis services in primary healthcareclinics in South Africa
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
por: Naicker, Nivashnee, et al.
Publicado: (2022)

Inclusion of adolescent girls in HIV prevention research – an imperative for an AIDS-free generation
por: Karim, Quarraisha Abdool, et al.
Publicado: (2014)

COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa
por: Abdool Karim, Quarraisha, et al.
Publicado: (2022)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression
por: Ngcobo, Samukelisiwe, et al.
Publicado: (2022)

Enhancing oral PrEP uptake among adolescent girls and young women in Africa
por: Heck, Craig J., et al.
Publicado: (2022)

Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk
por: Mwatelah, Ruth, et al.
Publicado: (2019)

Honing in on enteric fever
por: McKinnon, Lyle R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tq906crjhrfqbh8srk0lm2prrg